Shenzhen Weiguang Biological Products Co Ltd Strategic Asset Allocation Index
Shenzhen Weiguang Biological Products Co Ltd strategic asset allocation index. Shenzhen Weiguang Biological Products Co Ltd (002880) has a Strategic Asset Allocation Index of 56.7% as of September 2023. Strategic assets (PP&E of CN¥1.12 Billion plus long-term investments of CN¥-) total CN¥1.12 Billion, measured against net assets of CN¥1.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002880 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shenzhen Weiguang Biological Products Co Ltd (2016–2021)
Strategic asset allocation index of Shenzhen Weiguang Biological Products Co Ltd from 2016 to 2021. This chart shows how Shenzhen Weiguang Biological Products Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 56.7%, representing strategic assets of CN¥1.12 Billion against net assets of CN¥1.97 Billion CNY.
Shenzhen Weiguang Biological Products Co Ltd Strategic Asset Allocation Index by Year (2016–2021)
Shenzhen Weiguang Biological Products Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Weiguang Biological Products Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002880 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.9% | CN¥785.22 Million | CN¥785.22 Million | CN¥- | CN¥1.79 Billion | ▲ +9.1 pp |
| 2020 | 34.8% | CN¥565.30 Million | CN¥565.30 Million | CN¥- | CN¥1.62 Billion | ▲ +3.9 pp |
| 2019 | 30.9% | CN¥447.87 Million | CN¥447.87 Million | CN¥- | CN¥1.45 Billion | ▼ -1.6 pp |
| 2018 | 32.5% | CN¥424.27 Million | CN¥424.27 Million | CN¥- | CN¥1.31 Billion | ▼ -0.2 pp |
| 2017 | 32.6% | CN¥392.75 Million | CN¥392.75 Million | CN¥- | CN¥1.20 Billion | ▼ -41.2 pp |
| 2016 | 73.9% | CN¥374.02 Million | CN¥374.02 Million | CN¥- | CN¥506.44 Million | — |